Eikon Therapeutics, Inc. Common Stock ( EIKN) - Stock Earnings
EIKN Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Sept. 2, 2026, midnight | — / — | — | — / — | — |
EIKN Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -79.7 million USD | — USD |
| 2026Q1 | -83.0 million USD | — USD |
| 2026Q2 | -88.4 million USD | — USD |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
EIKN Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -242.0 million USD | — USD |
| 2024 | -243.8 million USD | — USD |
| 2025 | -324.2 million USD | — USD |
| 2026 Est. | — | — |
EIKN
Price: $10.75
52 week price:
Earnings Per Share: -5.95 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 598.5 million